-
James A Glazier
Dr. Glazier’s research focuses on early embryonic development, developmental and chronic toxicity and developmental diseases, with more than 70 experimental and computational papers on biological...
https://nanohub.org/members/191087
-
The Effects of Gold and Silver Nanoparticles on Brine Shrimp: A Toxicology Study
05 Apr 2016 | | Contributor(s):: NNCI Nano
This lab is designed to help students understand the following: the interdisciplinary fields of science, a practical application of chemistry in the real world, and the need to carefully conduct experiments and evaluate data in a collaborative environment. ...
-
Estefania Alvarado
https://nanohub.org/members/100521
-
State of Art of Nanotoxicology
20 Mar 2013 | | Contributor(s):: VEERA CSR CHITTEPU
Brief introduction to nanotoxicology and how computer modeling and simulations can help nanotoxociology research. free softwares and commercial softwares that are avialable from world wide web to calculate nanoQSAR.
-
Carbon Nanotube (CNT) Pulmonary Toxicity Data Set
14 Mar 2012 | | Contributor(s):: Jeremy M Gernand
This data set contains the collected in vivo pulmonary toxicity results contained in 18 published studies conducted between 2004 and 2011 with single- and multi-walled carbon nanotubes. These data include characterization measurements of the CNT samples as well as observed animal toxic responses...
-
Jeremy M Gernand
Jeremy Gernand is currently an Assistant Professor of Industrial Health and Safety at Penn State University. He is currently pursuing research related to the occupational hazards of exposure to...
https://nanohub.org/members/61288
-
BME 695L Lecture 16: FDA and EPA Regulatory Issues
02 Dec 2011 | | Contributor(s):: James Leary
See references below for related reading.16.1 Introduction and overview16.1.1 How does the FDA think about nanomedical systems?16.1.2 The 2006 Nanotechnology Task Force16.2 Some...
-
What We Know and Don’t Know About the Toxicity of Nanomaterials: Challenges in Developing Experimental Approaches for Safety Assessment
24 Dec 2010 | | Contributor(s):: Peter L Goering
This seminar will summarize recent research activities at CDRH/FDA and highlight issues en countered in the characterization and biological responses of some prototypic nanomaterials.
-
BME 695N Lecture 21: FDA and EPA Regulatory Issues
27 Nov 2007 | | Contributor(s):: James Leary
Outline:Introduction and overview How does the FDA think about nanomedical systems? The 2006 Nanotechnology Task Force Some details of the Nanotechnology Task Force Report General findings of the report Some initial recommendations of the Task Force Where the FDA may need to meet EPA on nanoscale...
-
Nanotechnologies, Science and Society: Promises and Challenges
10 May 2007 | | Contributor(s):: James Leary
-
Nanotechnology and Occupational Safety and Health: What are the Issues, What do we know, and What is NIOSH Doing
21 Nov 2006 | | Contributor(s):: Chuck L Geraci
Nanotechnology and Occupational Safety and Health: What are the Issues, What do we know, and What is NIOSH Doing